首页> 外文OA文献 >Primary cutaneous signet ring cell carcinoma expressing cytokeratin 20 immunoreactivity
【2h】

Primary cutaneous signet ring cell carcinoma expressing cytokeratin 20 immunoreactivity

机译:表达细胞角蛋白20免疫反应性的原发性皮肤印戒细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Primary cutaneous signet ring cell carcinoma (PCSRCC) is a very unusual but distinctive clinicopathologic entity that can simulate metastatic adenocarcinomas. It is defined as a diffuse malignant epithelial neoplasia localized in the dermis and subcutis without epidermal involvement, showing variable amounts of signet ring cells, without evidence of visceral adenocarcinoma. We present 2 cases of PCSRCC, which involved eyelids and axilla respectively. Despite thorough systemic workup, primary sources could not be demonstrated in either case. The tumor cells are positive for gross cystic disease fluid protein 15 in addition to a variety of glandular markers. Furthermore, both cases were immunostained with cytokeratin 20 (CK20). In conclusion, we report 2 cases of PCSRCC expressing CK20 immunoreactivity. CK20-positive primary cutaneous tumors should include PCSRCC in addition to Merkel cell carcinoma.
机译:原发性皮肤印戒细胞癌(PCSRCC)是一种非常不寻常但与众不同的临床病理学实体,可以模拟转移性腺癌。它的定义是弥漫性恶性上皮肿瘤,位于真皮和皮下组织,无表皮受累,显示出数量不等的印戒细胞,没有内脏腺癌的证据。我们目前有2例PCSRCC,分别涉及眼睑和腋窝。尽管进行了全面的系统检查,但两种情况均无法证明主要来源。除了多种腺标志物外,肿瘤细胞的总囊性囊病液蛋白15呈阳性。此外,这两种情况都用细胞角蛋白20(CK20)进行了免疫染色。总之,我们报告了2例表达CK20免疫反应性的PCSRCC病例。 CK20阳性的原发性皮肤肿瘤除默克尔细胞癌外还应包括PCSRCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号